Beatrice Bardy

La Tronche, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Kidney transplant outcomes in HLA desensitized patients with pretransplant CDC and/or FCM positive crossmatches.

Kidney transplant outcomes in HLA desensitized patients with pretransplant CDC and/or FCM positive crossmatches.

Journal: Frontiers in immunology

Published: April 15, 2025

Guidelines From the French-Speaking Society of Histocompatibility and Immunogenetics for Virtual Crossmatching for Deceased Donor Kidney Transplantation and the Use of Wet Crossmatch in the Decision-Making Process.

Guidelines From the French-Speaking Society of Histocompatibility and Immunogenetics for Virtual Crossmatching for Deceased Donor Kidney Transplantation and the Use of Wet Crossmatch in the Decision-Making Process.

Journal: HLA

Published: July 26, 2024

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study.

Tocilizumab Evaluation in HLA-Desensitization before Kidney Transplantation as an Add-On Therapy to Apheresis: The TETRA Study.

Journal: Journal of clinical medicine

Published: November 22, 2022

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization.

Tocilizumab Trough Levels Variability in Kidney-Transplant Candidates Undergoing Desensitization.

Journal: Journal of clinical medicine

Published: November 05, 2021

Immortal Time-Bias-Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients.

Immortal Time-Bias-Corrected Survival of Highly Sensitized Patients and HLA-desensitized Kidney Transplant Recipients.

Journal: Kidney international reports

Published: March 22, 2021

Characterization of the novel HLA-A*26:208 allele by sequencing-based typing.

Characterization of the novel HLA-A*26:208 allele by sequencing-based typing.

Journal: HLA

Published: March 01, 2021

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation.

Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation.

Journal: Journal of clinical medicine

Published: February 12, 2021

Treatment of antibody-mediated rejection with double-filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation.

Treatment of antibody-mediated rejection with double-filtration plasmapheresis, low dose IVIg plus rituximab after kidney transplantation.

Journal: Journal of clinical apheresis

Published: February 08, 2021

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates.

Marginal Impact of Tocilizumab Monotherapy on Anti-HLA Alloantibodies in Highly Sensitized Kidney Transplant Candidates.

Journal: Transplantation direct

Published: January 06, 2021

Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates.

Immune responses following tocilizumab therapy to desensitize HLA-sensitized kidney transplant candidates.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 04, 2021

Characterization of the novel HLA-B*15:514 allele in a French hematopoietic stem cell donor.

Characterization of the novel HLA-B*15:514 allele in a French hematopoietic stem cell donor.

Journal: HLA

Published: November 04, 2020

Characterization of the novel HLA-DQB1*05:236N null allele in a French hematopoietic stem cell donor.

Characterization of the novel HLA-DQB1*05:236N null allele in a French hematopoietic stem cell donor.

Journal: HLA

Published: April 28, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026